PuSH - Publication Server of Helmholtz Zentrum München: Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Napolitano, V. ; Dabrowska, A.* ; Schorpp, K.K. ; Mourao, A. ; Barreto-Duran, E.* ; Benedyk, M.* ; Botwina, P.* ; Brandner, S. ; Bostock, M.J. ; Chykunova, Y.* ; Czarna, A.* ; Dubin, G.* ; Fröhlich, T. ; Hölscher, M.* ; Jedrysik, M.* ; Matsuda, A.* ; Owczarek, K.* ; Pachota, M.* ; Plettenburg, O. ; Potempa, J.S.* ; Rothenaigner, I. ; Schlauderer, F. ; Slysz, K.* ; Szczepanski, A.* ; Greve-Isdahl Mohn, K.* ; Blomberg, B.* ; Sattler, M. ; Hadian, K. ; Popowicz, G.M. ; Pyrc, K.*

Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses.

Cell Chem. Bio. 29, 774-784.e8 (2022)

Publ. Version/Full Text

Research data

DOI

PMC

	Open Access Hybrid

Abstract
Metrics
Extra information

The COVID-19 pandemic caused by SARS-CoV-2 has been socially and economically devastating. Despite an unprecedented research effort and available vaccines, effective therapeutics are still missing to limit severe disease and mortality. Using high-throughput screening, we identify acriflavine (ACF) as a potent papain-like protease (PL^pro) inhibitor. NMR titrations and a co-crystal structure confirm that acriflavine blocks the PL^pro catalytic pocket in an unexpected binding mode. We show that the drug inhibits viral replication at nanomolar concentration in cellular models, in vivo in mice and ex vivo in human airway epithelia, with broad range activity against SARS-CoV-2 and other betacoronaviruses. Considering that acriflavine is an inexpensive drug approved in some countries, it may be immediately tested in clinical trials and play an important role during the current pandemic and future outbreaks.

Impact Factor

Scopus SNIP

Scopus
Cited By

Altmetric

9.039

1.698